Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.35M Buy
21,400
+16,600
+346% +$1.16M ﹤0.01% 2644
2026
Q1
$362K Sell
4,800
-58,200
-92% -$4.15M ﹤0.01% 3281
2025
Q4
$3.89M Buy
63,000
+31,300
+99% +$1.84M ﹤0.01% 2021
2025
Q3
$1.86M Sell
31,700
-139,900
-82% -$8.15M ﹤0.01% 1468
2025
Q2
$9.99M Sell
171,600
-54,300
-24% -$3.07M 0.02% 733
2025
Q1
$11.2M Buy
225,900
+137,400
+155% +$7.03M 0.03% 641
2024
Q4
$3.96M Buy
88,500
+45,200
+104% +$2.15M 0.01% 1025
2024
Q3
$2.08M Buy
+43,300
New +$2.09M 0.01% 1183

Other funds holding NTR

Steven Cohen's NTR Position: Q2 2026 in Review

Steven Cohen reduced its Nutrien (NTR) stake by 100% in Q2 2026, selling an estimated $44.7M and leaving 2,269 shares worth $142K. The position accounts for ﹤0.01% of the portfolio, ranked #3630.

Steven Cohen first reported a position in NTR in Q1 2018 and has held it in 17 quarters since. The position peaked at $88.5M in Q3 2023. 728 funds tracked by Wall St. Rank hold NTR as of Q2 2026.

  • Steven Cohen held 2,269 shares of Nutrien worth $142K as of Q2 2026.
  • Steven Cohen sold 639,519 Nutrien shares in Q2 2026, an estimated $44.7M.
  • Nutrien made up ﹤0.01% of Steven Cohen's portfolio in Q2 2026, its #3630 holding.
  • Steven Cohen first reported a position in Nutrien in Q1 2018 and has held it in 17 quarters since.
  • Steven Cohen's Nutrien position peaked at $88.5M in Q3 2023.
  • 728 funds tracked by Wall St. Rank held Nutrien as of Q2 2026.

Based on Point72 Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.